News
Members of Endo nursing staff present talks at 2022 National Conference of the Pediatric Endocrinology Nursing Society
Nikki Danis, MSN, RN, CPNP and Michelle Bockstruck, RN presented “Clinic Practice Models and Shared Appointments for High-Risk Diabetics” and Susan Davis, MSN (R), RN, APRN presented “Precocious Puberty in the Setting of Turners Syndrome – Expect the Unexpected” at the 2022 National Conference of the Pediatric Endocrinology Nursing Society.
Katie Burgener, MD, receives Endocrine Society Fellows Travel Award
Katie Burgener, MD (PG5 Fellow) received the Endocrine Society Fellows Travel Award to attend the Endocrine Society’s Annual Meeting and Type 1 Diabetes Fellows Series in Atlanta.
Sam Cortez, MD, to present abstract at Pediatric Endocrine Society national meeting
Sam Cortez, MD, (PG5 Fellow) will present his abstract “Monoclonal Cortisol Immunoassay Cut Off Point to Diagnose Adrenal Insufficiency (AI)” at the Pediatric Endocrine Society national meeting. It has been designated a Pediatric Endocrine Society Presidential Abstract; one of the top-ranking abstracts submitted by a trainee.
Michael Thompson, MD, PhD, received 2021 AASLD Gupta Family Pilot Research Award (Links to an external site)
Michael Thompson received the 2021 AASLD Gupta Family Pilot Research Award in Primary Sclerosing Cholangitis Research for his project “Role of Microbiome in Development of Offspring Cholestatic Liver Disease after Maternal Obesogenic Diet Exposure.”
Sam Cortez, MD, selected as fellow representative (Links to an external site)
Sam Cortez, MD, (PGY5 Fellow) was selected as a Fellow Representative for the Section on Pediatric Endocrinology at the American Academy of Pediatrics.
Recent publications
Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY) (Links to an external site)
Verma, M., & Stone, S. I. (2022). Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY), Endocrinology, Diabetes & Metabolism Case Reports, 2022, 21-0118. Retrieved Apr 28, 2022, from https://edm.bioscientifica.com/view/journals/edm/2022/1/EDM21-0118.xml
Association Between Endocrine Disorders and Severe COVID-19 Disease in Pediatric Patients (Links to an external site)
Banull NR, Reich PJ, Anka C, May J, Wharton K, Kallogjeri D, Shimony H, Arbeláez AM. Association Between Endocrine Disorders and Severe COVID-19 Disease in Pediatric Patients. Horm Res Paediatr. 2022 Apr 13. doi: 10.1159/000524595. Epub ahead of print. PMID: 35417912.
MATERNAL OBESOGENIC DIET ENHANCES CHOLESTATIC LIVER DISEASE IN OFFSPRING (Links to an external site)
Thompson MD, Hinrichs H, Faerber A, Tarr PI, Davidson NO. MATERNAL OBESOGENIC DIET ENHANCES CHOLESTATIC LIVER DISEASE IN OFFSPRING. J Lipid Res. 2022 Mar 24:100205. doi: 10.1016/j.jlr.2022.100205. Epub ahead of print. PMID: 35341737.
Maternal obesogenic diet regulates offspring bile acid homeostasis and hepatic lipid metabolism via the gut microbiome in mice (Links to an external site)
Thompson MD, Kang J, Faerber A, Hinrichs H, Özler O, Cowen J, Xie Y, Tarr PI, Davidson NO. Maternal obesogenic diet regulates offspring bile acid homeostasis and hepatic lipid metabolism via the gut microbiome in mice. Am J Physiol Gastrointest Liver Physiol. 2022 Mar 1;322(3):G295-G309. doi: 10.1152/ajpgi.00247.2021. Epub 2022 Jan 5. PMID: 34984925; PMCID: PMC8816615.
Maternal Fructose Diet-Induced Developmental Programming Nutrients (Links to an external site)
Thompson, MD and DeBosch, BJ. Maternal Fructose Diet-Induced Developmental Programming Nutrients. 2021;13(9).